期刊文献+

转染沉默IGFBP-2基因抑制食管癌细胞系TE-1增殖、转移的影响 被引量:1

The Effect of Transfecting and Silencing Gene IGFBP-2 on Inhibition of Proliferation and Metastasis of Esophageal Carcinoma Cell Line TE-1
下载PDF
导出
摘要 研究转染沉默IGFBP-2抑制食管癌细胞系TE-1增殖、转移的影响。通过构建好的IGFBP-2的SiRNA绿色荧光载体转染到人食管癌细胞系TE-1中,于荧光显微镜下观测转染效率,通过Western-blot证实基因沉默的效果,并通过CCK8,Transwell和流式来分别评估IGFBP-2-SiRNA对细胞增殖,侵袭和凋亡的影响。结果显示:Western-blot法证实IGFBP-2能有效地被SiRNA沉默,而且IGFBP-2-SiRNA能抑制食管癌细胞系TE-1的增殖\,侵袭和诱导凋亡。实验结果表明IGFBP-2在食管癌的发病机理中可能有着重要的作用。IGFBP-2也许能成为食管癌治疗的一个靶向基因。 This paper is to study the effect of transfecting and silencing gene IGFBP-2 on inhibition of proliferation and metastasis of esophageal carcinoma cell line TE-1.By transfecting IGFBP-2 to esophageal carcinoma cell line TE-1 through the ready SiRNA green fluorescent carrier,the transfection efficiency was observed under a fluorescence microscope,the effect of gene silencing was verified by means of western-blot,and the effect of IGFBP-2-SiRNA on cell proliferation,invasion and apoptosis was evaluated respectively with CCK8,Transwell and flow cytometry.The western-blot method confirmed that IGFBP-2 could be effectively silenced by SiRNA,and that IGFBP-2-SiRNA could inhibit the proliferation,invasion and induced apoptosis of esophageal carcinoma cell line TE-1.The experimental results show that IGFBP-2 may play an important role in the etiopathogenesis of esophageal cancer.IGFBP-2 may be a target gene for esophageal cancer treatment.
作者 张倬 熊飞 李雪曼 陈天佑 Zhang Zhuo;Xiong Fei;Li Xueman;Chen Tianyou(Department of Thoracic Surgery,The Third Hospital of Wuhan,Wuhan 430000,China)
出处 《甘肃科学学报》 2020年第1期32-37,共6页 Journal of Gansu Sciences
基金 武汉市卫计委基金资助项目(WX17D08)
关键词 IGFBP-2 食管癌 SIRNA TE-1 IGFBP-2 Esophageal cancer SiRNA TE-1
  • 相关文献

参考文献3

二级参考文献57

  • 1Ferlay J,Shin HR,Bray F. Estimates of worldwide burden of cancer in 2008:Globocan[J].{H}International Journal of Cancer,2010,(12):2893-2917.
  • 2Jemal A,Siegel R,Ward E. Cancer statistics,2009[J].{H}CA-A Cancer Journal for Clinicians,2009,(4):225-249.
  • 3Lepage C,Rachet B,Jooste V. Continuing,rapid increase in esophageal adenocarcinoma in England and Wales[J].{H}American Journal of Gastroenterology,2008,(11):2694-2699.
  • 4Pennathur A,Luketich JD. Resection for esophageal cancer:strategies for optimal management[J].{H}ANNALS OF THORACIC SURGERY,2008,(2):S751-S756.
  • 5Lordick F,Ott K,Krause B J. PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction:the MUNICON phase Ⅱ trial[J].{H}LANCET ONCOLOGY,2007,(9):797-805.
  • 6Biere SS,van Berge Henegouwen MI,Maas KW. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer:a multicentre,open-label,randomised controlled trial[J].{H}LANCET,2012,(9829):1887-1892.
  • 7Pennathur A,Zhang J,Chen H. The "best operation" for esophageal cancer[J].{H}ANNALS OF THORACIC SURGERY,2010,(6):S2163-S2167.
  • 8Hulscher JB,van Sandick JW,de Boer AG. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus[J].{H}New England Journal of Medicine,2002,(21):1662-1669.
  • 9Omloo JM,Lagarde SM,Hulscher JB. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus:five-year survival of a randomized clinical trial[J].{H}ANNALS OF SURGERY,2007,(6):992-1000.
  • 10Shaheen NJ,Sharma P,Overholt BF. Radiofrequency ablation in Barrett 's esophagus with dysplasia[J].{H}New England Journal of Medicine,2009,(22):2277-2288.

共引文献31

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部